Glenmark Life Sciences’ Q1FY25 results shock industry with 9.7% revenue surge
Glenmark Life Sciences Limited (BSE: 543322, NSE: GLS), a prominent player in the pharmaceutical industry, has announced impressive financial results for the quarter ended June 30, 2024. The company’s revenue surged by 9.7% quarter-on-quarter (QoQ), reaching ₹5,886 million. This growth reflects a solid 1.8% increase year-on-year (YoY), underlining Glenmark Life Sciences’ strong performance amidst challenging […]